logo
Aetherium Acquisition Corp. Announces Change of Special Meeting Date

Aetherium Acquisition Corp. Announces Change of Special Meeting Date

Business Upturn15 hours ago

GREENWICH, Conn., June 13, 2025 (GLOBE NEWSWIRE) — Aetherium Acquisition (the 'SPAC' or the 'Company'), a publicly-traded special purpose acquisition company, today announced that its Special Meeting ('Meeting'), previously scheduled at 8:30 a.m. Eastern Time on June 13, 2025, has been postponed to 8:30 a.m. Eastern Time on June 27, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on June 25, 2025.
The record date for the Meeting remains May 9, 2025. No changes have been made to the proposals to be voted on by shareholders at the Meeting. Shareholders of the Company who have previously submitted their proxy and who do not want to change their vote do not need to take any action.
On May 23, 2025, the Company filed a definitive proxy statement with the Securities and Exchange Commission (the 'SEC') and on June 3, 2025, the Company filed a revised definitive proxy statement with the SEC, each in connection with its solicitation of proxies for the Meeting. Before making any voting decision, investors and shareholders of the company are urged to read the definitive proxy statement (including any amendments or supplements thereto) and other documents the company files with the sec carefully in their entirety when they become available as they will contain important information. Investors and shareholders will be able to obtain free copies of the definitive proxy statement (including any amendments or supplements thereto) and other documents filed or that will be filed with the SEC through the web site maintained by the SEC at www.sec.gov.
About Aetherium Acquisition Corp.
Aetherium Acquisition Corp. is a blank check company formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Efforts to identify a prospective target business will not be limited to a particular business, industry sector, or geographical region. However, it intends to focus on companies in Asia (excluding China).
Forward-looking Statements
This press release contains statements that may constitute 'forward-looking statements,' including with respect to Aetherium's pursuit of an alternative business combination. No assurance can be given that Aetherium will successfully seek and consummate such an alternative business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Aetherium, including those set forth in the Risk Factors section of Aetherium's public filings with the Securities and Exchange Commission. Copies are available on the SEC's website, www.sec.gov. Aetherium undertakes no obligation to update these statements for revisions or changes after the date of this release except as required by law.
Participants in the Solicitation
The Company and its directors, executive officers, other members of management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies from the shareholders of the Company in connection with the Meeting. Investors and shareholders may obtain more detailed information regarding the names, affiliations and interests of the Company's directors and officers in the Proxy Statement, which may be obtained free of charge from the sources indicated above.
No Offer or Solicitation
This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Meeting proposals. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.
Contact:
For investors: Crocker Coulson, CEO, AUM Media+1 (646) 652-7185
[email protected];
[email protected]

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sturm Ruger CEO sees 2025 bottom line impacted by price repositioning moves
Sturm Ruger CEO sees 2025 bottom line impacted by price repositioning moves

Yahoo

time3 hours ago

  • Yahoo

Sturm Ruger CEO sees 2025 bottom line impacted by price repositioning moves

On June 13, Sturm, Ruger & Company provided a communication from Todd Seyfert, CEO, to its employees regarding his first 100 days and management's ongoing corporate strategy initiatives, the company disclosed in a regulatory filing. In the letter to employees, Seyfert stated in part: 'The last few months have been nothing short of transformative – and it's thanks to your focus, dedication, and belief in what we're building. As I have been doing since my first days as CEO, I wanted to update you all transparently and clearly about where I see our short-term and long-term future… With these bold moves, there comes a cost – both emotionally and financially. Change of this scale requires tough decisions, meaningful investment, and short-term impacts that we've chosen to take head-on to position Ruger for long-term strength… It is important to note that we are making these strategic decisions now – thoughtfully and intentionally – so that Ruger is positioned for consistency, stability, and profitable growth in 2026 and beyond. Yet, there will be a cost to the Company for 2025. We expect the expense-related to these initiatives to total approximately $15 million to $20 million over the remainder of the year. We additionally anticipate our price repositioning moves to impact our overall bottom line over that same period. Consequently, we currently believe that our results for the remainder of the year, before the one-time costs and expenses, will look more like prior periods, such as the latter part of 2019, where the Company continued to focus on executing its long-term strategy and delivering long-term value for shareholders in the face of broader industry challenges. These actions will be largely completed by the beginning of 2026, placing Ruger in a strong position for renewed growth and performance in the years to come. Importantly, none of this will slow our momentum when it comes to investing in what matters most, including aggressive new product development and expansion of capacity in areas where market demand exceeds our current ability to supply. We remain fully committed to profitable expansion, product innovation, agile responsiveness, and ensuring we meet the expectations of our customers and the marketplace.' Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on RGR: Disclaimer & DisclosureReport an Issue Sturm Ruger Announces Strategic Initiatives Under New CEO Supreme Court blocks Mexico suit against gunmakers Sturm Ruger Appoints New General Counsel Sturm Ruger Amends By-Laws for Shareholder Actions Sturm Ruger Reports Stable Q1 2025 Financial Results Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Chanson International prices 16M units at 50c in public offering
Chanson International prices 16M units at 50c in public offering

Yahoo

time3 hours ago

  • Yahoo

Chanson International prices 16M units at 50c in public offering

Chanson International (CHSN) has priced a best-efforts public offering with gross proceeds to the Company expected to be approximately $8M, before deducting placement agent fees and other estimated expenses payable by the Company, excluding the exercise of any warrant offered. The offering is comprised of 16,000,000 units, consisting of one Class A ordinary share of the Company, par value $0.001 per share, or in lieu thereof, a pre-funded warrant, one series A warrant to purchase one Class A Ordinary Share and one series B warrant to purchase one Class A Ordinary Share. The public offering price of the Units is $0.50 per Unit. Each of the Series A Warrants and the Series B Warrants will have an exercise price of $0.525 per Class A Ordinary Share and be exercisable beginning on the date of the issuance date and ending on the two and half anniversary of the issuance date. The offering is expected to close on or about June 16, 2025, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from this offering to open new stores in China and in the U.S., and the specific allocation of net proceeds to each market will be based on market conditions. Univest Securities is acting as sole placement agent for the offering. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on CHSN: Disclaimer & DisclosureReport an Issue Chanson International files to sell 25M units on 'best-efforts basis' Chanson International Innovates with New Natural Sweetener Blend Chanson International announces self-developed 'Songkang Meal' series Chanson reports on diversity initiatives, responsible business practices Chanson International announces new formulation for sugar Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données

Rapt Therapeutics announces effective date for 1-for-8 reverse stock split
Rapt Therapeutics announces effective date for 1-for-8 reverse stock split

Yahoo

time3 hours ago

  • Yahoo

Rapt Therapeutics announces effective date for 1-for-8 reverse stock split

RAPT Therapeutics (RAPT) announced that a 1-for-8 reverse stock split of its outstanding shares of common stock will be effective at 11:59 pm Eastern Time June 16, 2025. Following the reverse stock split, the Company's common stock will continue to trade on the Nasdaq Global Market under the symbol 'RAPT' with the new CUSIP number 75382E 208. The Company's common stock will begin trading on a reverse stock split-adjusted basis on June 17, 2025. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on RAPT: Disclaimer & DisclosureReport an Issue RAPT Therapeutics Announces Development Plans for RPT904 Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity Rapt Therapeutics initiated with a Buy at Clear Street RAPT Therapeutics Faces Nasdaq Delisting Notice Rapt Therapeutics price target lowered to $1 from $2 at UBS Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store